Promising antileishmanial activity of novel imidazole antifungal drug Luliconazole against Leishmania major: in vitro and in silico studies
Conclusion These results showed the potent activity of Luliconazole in extremely low concentration against L. major; therefore, it could be considered as a new candidate for treatment of leishmaniasis in the close future. Graphical abstract
Source: Journal of Global Antimicrobial Resistance - Category: Infectious Diseases Source Type: research
More News: Abelcet | Antimicrobial Resistance | HIV-Leishmania Co-infection | Infectious Diseases | Ketoconazole | Parasitic Diseases | Parasitology | Study | Toxicology